Search
Research
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trialA range of safe and effective vaccines against SARS CoV 2 are needed to address the COVID 19 pandemic. We aimed to assess the safety and efficacy of the COVID-19 vaccine SCB-2019.
Research
VaccinationVaccination is the injection of an inactivated bacteria or virus into the body. This simulated infection allows an individual's immune system to develop an adaptive immunity for protection against that type of illness. When a sufficiently large percentage of a population has been vaccinated, this results in herd immunity.
News & Events
Community Conversation- Infectious Diseases in ChildrenConsumers and community members are invited to join us to provide input into our childhood infectious diseases research.
News & Events
Vaccination timing essentialWe all know how important it is to vaccinate a child against harmful diseases but vaccinating a child at the right wrong age can cost lives.
News & Events
Experts gather for Aboriginal Immunisation WorkshopExperts in Aboriginal infectious disease research are in Perth this week for the National Indigenous Immunisation Research Workshop (November 7-8).
News & Events
New vaccine could protect against more types of cancer-causing HPVTrial of new vaccine that could provide women with additional protection against Human Papillomavirus (HPV) types known to cause cervical cancer.
News & Events
Perth women needed for international cervical cancer studyPerth women are being invited to take part in a global study of an exciting new vaccine that could protect against cervical cancer
News & Events
Meningococcal research paves way for vaccine useA series of The Kids Research Institute Australia studies looking at safety for Meningococcal ACWY vaccines in children has led the way for its use in Australia.
Research
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.The global spread of the 2009 novel pandemic influenza A (H1N1) virus led to the accelerated production and distribution of monovalent 2009 Influenza A...